N. Arvold

发表

Aggressive therapy for patients with non-small cell lung carcinoma and synchronous brain-only oligometastatic disease is associated with long-term survival.

Laura W. Christianson, R. Mak, B. Yeap, 2014, Lung cancer.

Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy.

Barbara L. Smith, A. Niemierko, J. Bellon, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

PKB/Akt mediates radiosensitization by the signaling inhibitor LY294002 in human malignant gliomas

J. Nakamura, N. Arvold, D. Stokoe, 2005, Journal of Neuro-Oncology.

Steroid and anticonvulsant prophylaxis for stereotactic radiosurgery: Large variation in physician recommendations.

B. Alexander, N. Pinnell, N. Arvold, 2016, Practical radiation oncology.

Primary Colorectal Cancer

C. Willett, N. Arvold, V. Valentini, 2011 .

Risk of death from prostate cancer after radical prostatectomy or brachytherapy in men with low- or intermediate-risk disease.

A. D'Amico, J. Moul, N. Arvold, 2011, Journal of Clinical Oncology.

Signal transduction molecules in gliomas of all grades

M. Berger, K. Lamborn, N. Arvold, 2007, Journal of Neuro-Oncology.

Lower-Dose Stereotactic Radiosurgery for Small Brain Metastases: Local Control and Toxicity

Laura W. Christianson, Mark D. Johnson, A. Golby, 2014 .

Importance of extracranial disease status and tumor subtype for patients undergoing radiosurgery for breast cancer brain metastases.

N. Lin, E. Lee, B. Alexander, 2012, International journal of radiation oncology, biology, physics.

Hypofractionated versus standard radiation therapy with or without temozolomide for older glioblastoma patients.

Laura W. Christianson, Mark D. Johnson, P. Wen, 2015, International journal of radiation oncology, biology, physics.

Involvement of Radiation Oncologists in Multidisciplinary Decision-making for Early-Stage Lung Cancer.

N. Arvold, 2022, JAMA network open.

A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy.

Katrina H. Smith, P. Wen, E. Wong, 2014, Neuro-oncology.

Pancreatic Neuroendocrine Tumors With Involved Surgical Margins: Prognostic Factors and the Role of Adjuvant

Jeffrey W. Clark, A. Niemierko, C. Willett, 2012 .

Clinical Investigation : Gastrointestinal Cancer Pancreatic Neuroendocrine Tumors With Involved Surgical Margins : Prognostic Factors and the Role of Adjuvant Radiotherapy

Jeffrey W. Clark, A. Niemierko, C. Willett, 2022 .

Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma.

Mark D. Johnson, R. Beroukhim, P. Wen, 2014, Neuro-oncology.

Local control after fractionated stereotactic radiation therapy for brain metastases

Laura W. Christianson, Mark D. Johnson, A. Golby, 2014, Journal of Neuro-Oncology.

Brain metastases.

Steven D Chang, S. Peters, G. Harsh, 2019, Nature reviews. Disease primers.

The role of whole brain radiation therapy in the management of melanoma brain metastases

F. Hodi, E. Lee, B. Alexander, 2014, Radiation Oncology.

Marantic endocarditis with cardioembolic strokes mimicking leptomeningeal metastases in breast cancer.

N. Arvold, S. Weiss, Wendy Y Chen, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of Low-dose Chest CT Screening on the Association Between Rurality and Lung Cancer Outcomes

N. Arvold, Xuan Li, Nils D. Arvold, 2022, American journal of clinical oncology.

The impact of different stereotactic radiation therapy regimens for brain metastases on local control and toxicity

A. Niemierko, H. Shih, B. Alexander, 2017, Advances in radiation oncology.

Visual outcome and tumor control after conformal radiotherapy for patients with optic nerve sheath meningioma.

H. Shih, J. Rizzo, N. Arvold, 2007, International journal of radiation oncology, biology, physics.

Acknowledgement of Reviewers 2012

Steven D Chang, A. Friedman, D. Brat, 2013, Dysphagia (New York. Print).

Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)

P. Brown, M. Mehta, H. Shih, 2017, JAMA oncology.

Radiation-induced caspase-8 mediates p53-independent apoptosis in glioma cells.

N. Arvold, D. Haas-Kogan, G. Yount, 2006, Cancer research.

Maternal HIV-1 DNA load and mother-to-child transmission.

N. Arvold, K. Mcintosh, S. Piyaworawong, 2007, AIDS patient care and STDs.

Treatment options and outcomes for glioblastoma in the elderly patient

D. Reardon, N. Arvold, Nils D. Arvold, 2014, Clinical interventions in aging.

Brain metastases

S. Peters, G. Harsh, R. Soffietti, 2019, Nature Reviews Disease Primers.

Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastasis.

N. Yeh, B. Kavanagh, K. Beal, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib.

M. Berger, M. Prados, K. Lamborn, 2005, Journal of the National Cancer Institute.

Hypoxia-induced radioresistance is independent of hypoxia-inducible factor-1A in vitro.

N. Arvold, R. Warren, D. Haas-Kogan, 2005, International journal of radiation oncology, biology, physics.

Incidence, risk factors, and reasons for hospitalization among glioblastoma patients receiving chemoradiation

Mark D. Johnson, R. Beroukhim, P. Wen, 2015, Journal of Neuro-Oncology.

A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma.

R. Beroukhim, P. Wen, K. Ligon, 2015, Neuro-oncology.

Extent of resection and overall survival for patients with atypical and malignant meningioma

R. Beroukhim, P. Wen, A. Norden, 2015, Cancer.

Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma.

Mark D. Johnson, P. Kantoff, R. Beroukhim, 2015, Neuro-oncology.

Comparative effectiveness of radiotherapy with vs. without temozolomide in older patients with glioblastoma

Corwin M Zigler, Corwin M. Zigler, F. Dominici, 2016, Journal of Neuro-Oncology.

Hospitalization burden and survival among older glioblastoma patients.

F. Dominici, Yun Wang, D. Schrag, 2014, Neuro-oncology.

Recurrent radiation necrosis in the brain following stereotactic radiosurgery.

N. Arvold, I. Dunn, S. Ramkissoon, 2015, Practical radiation oncology.

Outcomes in stage I testicular seminoma: A population‐based study of 9193 patients

Ming-Hui Chen, D. Kuban, A. Ng, 2013, Cancer.

Brain metastases after breast-conserving therapy and systemic therapy: incidence and characteristics by biologic subtype

A. Niemierko, A. Taghian, N. Lin, 2012, Breast Cancer Research and Treatment.

Salvage whole brain radiotherapy or stereotactic radiosurgery after initial stereotactic radiosurgery for 1–4 brain metastases

Mark D. Johnson, A. Golby, B. Alexander, 2015, Journal of Neuro-Oncology.

Model averaged double robust estimation

Giovanni Parmigiani, Matthew Cefalu, Francesca Dominici, 2017, Biometrics.

Invasive lobular carcinoma of the breast: local recurrence after breast-conserving therapy by subtype approximation and surgical margin

J. Brock, N. Arvold, L. Braunstein, 2015, Breast Cancer Research and Treatment.

Pancreatic cancer tumor size on CT scan versus pathologic specimen: implications for radiation treatment planning.

A. Niemierko, N. Arvold, T. Hong, 2011, International journal of radiation oncology, biology, physics.

Updates in the management of brain metastases.

Eudocia Q Lee, Brian M Alexander, Riccardo Soffietti, 2016, Neuro-oncology.

Brachytherapy in the treatment of recurrent aggressive falcine meningiomas

P. Devlin, D. Reardon, N. Arvold, 2015, Journal of Neuro-Oncology.

Diagnostic accuracy of 2-hydroxyglutarate magnetic resonance spectroscopy in newly diagnosed brain mass and suspected recurrent gliomas

Raymond Y Huang, P. Wen, D. Reardon, 2017, Neuro-oncology.

In Reply to Levra et al.

B. Alexander, N. Arvold, S. Tanguturi, 2015, International journal of radiation oncology, biology, physics.

Radiotherapy and death from cerebrovascular disease in patients with primary brain tumors

P. Wen, R. Du, N. Arvold, 2015, Journal of Neuro-Oncology.

Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situ

Wei Jiang, J. Niland, S. Edge, 2012, Cancer.

Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group

Susan M. Chang, P. Wen, L. Deangelis, 2018, Neuro-oncology.

Impact of pemetrexed on intracranial disease control and radiation necrosis in patients with brain metastases from non-small cell lung cancer receiving stereotactic radiation.

P. Brown, P. Wen, A. Redig, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Evaluation of initial setup accuracy and intrafraction motion for spine stereotactic body radiation therapy using stereotactic body frames.

D. Sher, N. Arvold, F. Hacker, 2016, Practical radiation oncology.

The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases.

P. Brown, M. Mehta, H. Shih, 2016, International journal of radiation oncology, biology, physics.

Combined whole genome copy number genotyping and multiplex somatic mutation profiling of FFPE brain tumor specimens for clinical diagnosis and trial selection.

R. Beroukhim, P. Wen, K. Ligon, 2013 .

Long‐term outcomes of neoadjuvant chemotherapy before chemoradiation for locally advanced pancreatic cancer

Jeffrey W. Clark, A. Niemierko, A. Zhu, 2012, Cancer.

The role of whole brain radiation therapy in the management of melanoma brain metastases

F. Hodi, E. Lee, N. Ibrahim, 2014, Radiation Oncology.

Risk of death from prostate cancer after radical prostatectomy or brachytherapy in men with low or intermediate risk disease.

A. D'Amico, Ming-Hui Chen, J. Moul, 2011, The Journal of urology.

Berberine sensitizes human glioma cells, but not normal glial cells, to ionizing radiation in vitro.

N. Arvold, D. Haas-Kogan, G. Yount, 2004, Journal of experimental therapeutics & oncology.

Projected second tumor risk and dose to neurocognitive structures after proton versus photon radiotherapy for benign meningioma.

A. Niemierko, H. Shih, B. Fullerton, 2012, International journal of radiation oncology, biology, physics.

Margin status and the risk of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy

A. Niemierko, J. Bellon, S. Troyan, 2013, Breast Cancer Research and Treatment.

Tumor Hypoxia Response After Targeted Therapy in EGFR-Mutant Non-Small Cell Lung Cancer

L. Sequist, U. Mahmood, N. Arvold, 2016, Technology in cancer research & treatment.

Long-term Survival and Competing Causes of Death in Men with Stage I Seminoma

Ming-Hui Chen, K. Hoffman, A. Ng, 2010 .

Propensity scores with misclassified treatment assignment: a likelihood‐based adjustment

Danielle Braun, Malka Gorfine, Giovanni Parmigiani, 2017, Biostatistics.

Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone

Mark D. Johnson, P. Wen, K. Ligon, 2017, Journal of Neuro-Oncology.

Local therapies for brain metastases, competing risks, and overall survival.

P. Catalano, N. Arvold, Nils D. Arvold, 2015, International journal of radiation oncology, biology, physics.